Association between migraine prevalence, treatment with proton-pump inhibitors and CYP2C19 phenotypes in UK Biobank

Association between migraine prevalence, treatment with proton-pump inhibitors and CYP2C19 phenotypes in UK Biobank

Proton-pump inhibitors (PPIs) are used to suppress gastric acid secretion in several gastrointestinal conditions. While these drugs are generally well tolerated, their long-term use may be associated with different adverse effects, including migraine. We analyzed the association between treatment wi...

Full description

Bibliographic Details
Main Authors: Claudia Pisanu, Nike Zoe Welander, Gull Rukh, Helgi Birgir Schiöth, Jessica Mwinyi
Format: Article
Language:English
Published: Elsevier 2021-11-01
Series:Biomedicine & Pharmacotherapy
Subjects:
migraine
proton-pump inhibitors
CYP2C19
pharmacogenetics
gender differences
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332221010180

Internet

http://www.sciencedirect.com/science/article/pii/S0753332221010180

Similar Items